期刊
ONCOGENE
卷 34, 期 21, 页码 2753-2763出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/onc.2014.213
关键词
-
资金
- Else Kroner-Fresenius Foundation [2012_A20]
Aberrant signaling via G protein-coupled receptors (GPCRs) is implicated in numerous diseases including colon cancer. The heterotrimeric G proteins transduce signals from GPCRs to various effectors. So far, the G protein subunit G beta 5 has not been studied in the context of cancer. Here we demonstrate that G beta 5 protects colon carcinoma cells from apoptosis induced by the death ligand TRAIL via different routes. The G beta 5 protein (i) causes a decrease in the cell surface expression of the TRAIL-R2 death receptor, (ii) induces the expression of the anti-apoptotic protein XIAP and (iii) activates the NF-kappa B signaling pathway. The intrinsic resistance to TRAIL-triggered apoptosis of colon cancer cells is overcome by antagonization of G beta 5. Based on these results, targeting of G proteins emerges as a novel therapeutic approach in the experimental treatment of colon cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据